Project Number 5R33AG057289-05 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Optimal Medication Management in Alzheimer's Disease and Dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category E. Dementia Care and Impact of Disease 1. Identifying, Assessing and Improving Care and Quality of Life for Persons with Dementia a. Interventions in formal care settings Researcher and Organization Principal Investigator BAYLISS, ELIZABETH A Principal Investigator First Name ELIZABETH Principal Investigator Last Name BAYLISS Awardee Organization KAISER FOUNDATION RESEARCH INSTITUTE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-17-059: Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33) FY Overall Cost $619,216 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SALIVE, MARCEL
